154 related articles for article (PubMed ID: 28528915)
1. Sphingosine metabolism as a therapeutic target in cutaneous melanoma.
Dany M
Transl Res; 2017 Jul; 185():1-12. PubMed ID: 28528915
[TBL] [Abstract][Full Text] [Related]
2. New Insights into the Role of Sphingolipid Metabolism in Melanoma.
Carrié L; Virazels M; Dufau C; Montfort A; Levade T; Ségui B; Andrieu-Abadie N
Cells; 2020 Aug; 9(9):. PubMed ID: 32858889
[TBL] [Abstract][Full Text] [Related]
3. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
[TBL] [Abstract][Full Text] [Related]
4. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities.
Lai M; La Rocca V; Amato R; Freer G; Pistello M
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336922
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches.
Burns TA; Luberto C
Anticancer Agents Med Chem; 2011 Nov; 11(9):863-81. PubMed ID: 21707485
[TBL] [Abstract][Full Text] [Related]
7. Melanoma genetics: the other side.
Bis S; Tsao H
Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer.
Camp ER; Patterson LD; Kester M; Voelkel-Johnson C
Cancer Biol Ther; 2017 Sep; 18(9):640-650. PubMed ID: 28686076
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
Ekiz HA; Baran Y
Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase-1--a potential therapeutic target in cancer.
Cuvillier O
Anticancer Drugs; 2007 Feb; 18(2):105-10. PubMed ID: 17159597
[TBL] [Abstract][Full Text] [Related]
11. P53 in skin cancer: From a master player to a privileged target for prevention and therapy.
Loureiro JB; Abrantes M; Oliveira PA; Saraiva L
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188438. PubMed ID: 32980466
[TBL] [Abstract][Full Text] [Related]
12. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
13. Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.
Shaw J; Costa-Pinheiro P; Patterson L; Drews K; Spiegel S; Kester M
Adv Cancer Res; 2018; 140():327-366. PubMed ID: 30060815
[TBL] [Abstract][Full Text] [Related]
14. A therapeutic opportunity in melanoma: ErbB4 makes a mark on skin.
Settleman J
Cancer Cell; 2009 Oct; 16(4):278-9. PubMed ID: 19800573
[TBL] [Abstract][Full Text] [Related]
15. Mining database for the expression and gene regulation network of JAK2 in skin cutaneous melanoma.
Zhang W; Zhao H; Chen J; Zhong X; Zeng W; Li Z; Zhou J; He Z; Tang S
Life Sci; 2020 Jul; 253():117600. PubMed ID: 32234492
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
17. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
18. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
[TBL] [Abstract][Full Text] [Related]
19. Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.
Hiscutt EL; Hill DS; Martin S; Kerr R; Harbottle A; Birch-Machin M; Redfern CP; Fulda S; Armstrong JL; Lovat PE
J Invest Dermatol; 2010 Sep; 130(9):2250-8. PubMed ID: 20520630
[TBL] [Abstract][Full Text] [Related]
20. Bench to bedside: mechanistic principles of targeting the RAF kinase in melanoma.
Rajakulendran T; Adam DN
Int J Dermatol; 2014 Dec; 53(12):1428-33. PubMed ID: 25311997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]